Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon

Prog Clin Biol Res. 1992:378:225-33.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / therapy*
  • Humans
  • Immunotherapy*
  • Interferon-alpha / administration & dosage
  • Interleukin-2 / administration & dosage
  • Kidney Neoplasms / therapy*
  • Killer Cells, Lymphokine-Activated / immunology
  • Middle Aged

Substances

  • Interferon-alpha
  • Interleukin-2